The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in diabetic patients with coronary artery disease
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2014
At a glance
- Drugs Sitagliptin (Primary) ; Metformin
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IMAGINE-KOBE
- 05 Aug 2012 Actual initiation date added as reported by University Hospital Medical Information Network - Japan record.
- 12 Jul 2012 New trial record
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.